Abattis Bioceuticals (ATTBF) 0.1570 $ATTBF
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 68.08 (+1.82), FULL: 4.76 (-0.01)
Enertopia Provides Footage of Planned MMPR Facility
ACCESSWIRE - Thu Nov 20, 8:45AM CST
Whitefish, MT / ACCESSWIRE / November 20, 2014 / Thus far there has only been a handful of companies approved by Health Canada for the MMPR program, including Tweed Inc. (TSX-V: TWD) and Organigram Inc. (TSX-V: OGI), while a number of other companies, such as Abattis Bioceuticals (OTC: ATTBF) continue to await their approvals from Health Canada.
OGI.VN: 0.680 (+0.030), TWD.VN: 2.000 (-0.020)
Abattis Names Jaouad Fichtali as Chief Technology Officer
Marketwired - Wed Nov 19, 2:49PM CST
Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Jaouad Fichtali will assume the role of Chief Technology Officer of Abattis effective November 17, 2014.
Court Orders Abattis Bioceuticals to Cease Emergency Motions Against Affinor Growers Inc., Affinor Growers LLC and Nick Brusatore. Judge Agrees There is No Basis for Such Claims by Abattis
Marketwired - Wed Nov 12, 7:24AM CST
Affinor Growers (CSE: AFI)(OTCQB: RSSFF)(FRANKFURT: 1AF) ("Affinor" or the "Corporation) In a Temporary Restraining Order hearing in Washington State, the court ordered that Affinor Growers Inc., Affinor Growers LLC and Nick Brusatore should not be included in these proceedings. Brusatore's lawyer, Kevin Sullivan, explained that there was no basis for such claims, and the judge agreed.
Abattis Obtains Emergency Temporary Restraining Order Against Defendants In King County, Washington State Court--Court Sets "SHOW Cause" Hearing Against Defendants For November ...
ACCESSWIRE - Tue Nov 11, 11:07AM CST
Vancouver, BC / ACCESSWIRE / November 11, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, wishes to advise its shareholders that late Monday afternoon, the Company obtained a temporary restraining order from the Washington state court in King County against Herbal Analytics, LLC, James Baxter, Kaleb Lund, Lauren Hilty, and Erin Leary (the "HA Defendants" . The Company agreed with the court to defer any action against Affinor Growers, Affinor Growers, LLC and Nicholas Brusatore, personally, until after the conclusion of a "Show Cause" hearing on preliminary injunctive relief. The Show Cause hearing is scheduled for argument on November 24, 2014 at which time all of the defendants must prove why a temporary injunction should not be entered by the court.
Abattis Obtains Emergency Temporary Restraining Order Against Defendants In King County, Washington State Court--Court Sets "SHOW Cause" Hearing Against Defendants For November 24 Regarding the Imposition of a Preliminary Injunction
TheNewswire.ca - Tue Nov 11, 11:00AM CST
(via Thenewswire.ca)
Abattis Legal Action Goes From Federal to Washington State Court
ACCESSWIRE - Mon Nov 10, 4:01AM CST
Vancouver, BC /ACCESSWIRE / November 10, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that end of day Friday November 7th the company filed its suit in King County Superior Court, that it had previously filed in Federal court. It was filed end of day Friday. The hearing on it's motion for a temporary restraining order is scheduled Monday at 1:30 pm.
Abattis Legal Proceedings Update
ACCESSWIRE - Fri Nov 07, 5:01PM CST
Vancouver, BC / ACCESSWIRE / November 7, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that the U.S. Federal Court in Washington State has this morning declined to exercise federal jurisdiction over the Company's recently announced claims. As a preliminary jurisdictional matter, the court indicated that it did not believe it was an appropriate venue for legal proceedings relating to the state's Marijuana industry. While the Court stated that the Company had fought "valiantly" during the hearing in advocating for federal jurisdiction, it also made plain that, unlike other jurisdictions throughout the U.S. which had exercised jurisdiction, it was bound by a prior legal decision from the ninth circuit that narrowed the ability of the Court to exercise federal jurisdiction in a similar case. The Court took the extraordinary step, however, of warning the defendants that it's decision to decline exercising federal jurisdiction should not be considered "a win" as the Company was likely to refile it's allegations in Washington state court. As predicted in the ruling, the Company is in preparations to immediately refile its complaint and seek a temporary restraining order on an emergency basis in Washington state court. Unlike the federal system, Washington state courts generally align more closely with state law on claims based on disputes within the Marijuana industry. The Company will keep shareholders informed as information becomes available throughout the day.
Abattis Files for Injunctive Relief in Washington State and Claims Damages Against Former Employees, Business Associates and Competitor, Affinor Growers, Inc. and Certain of its...
ACCESSWIRE - Fri Oct 24, 2:41PM CDT
Vancouver, BC / ACCESSSWIRE / October 24, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that it has today, in U.S. Federal court in Washington State, filed suit for damages and injunctive relief against prior employees of PhytaLab (Dr. Kaleb Lund and Ms. Lauren Hilty), a former business associate (James Baxter), a competitor (Affinor Growers, Inc.), its director and former Abattis director (Nick Brusatore) and an employee of Herbal Analytics LLC (Erin Leary).
Abattis Announces New Investor Relations Appointment
ACCESSWIRE - Thu Oct 16, 8:16AM CDT
Vancouver, BC / ACCESSWIRE / October 16, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that they have entered into an Investor Relations Consulting Agreement with Satvir (Saf) Dhillon.
Abattis Announces Zoning Approval on the Experion MMPR Application
GlobeNewswire - Wed Oct 08, 8:48AM CDT
Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX:ATTBF) (CSE:ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that through its wholly owned subsidiary, Northern Vine Canada Inc. ("Northern Vine" , Experion Biotechnologies Inc. ("Experion" has received a written update from the Fraser Valley Regional District on the amended zoning regulations for its property which has now been approved for... "the use of cultivation, growth, storage, or distribution, testing, or research, of marijuana for medical purposes as lawfully permitted and authorized under the applicable federal or provincial law."
Abattis Announces Appointment Guy Dancosse, Q.C. to Board of Directors
ACCESSWIRE - Tue Sep 16, 7:06AM CDT
Vancouver, BC - / ACCESSWIRE / September 16, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Guy Dancosse, Q.C. has agreed to join the Board effective immediately as an independent Director.
Abattis' Phytalab Receives Cannabis Lab Certification in Washington
ACCESSWIRE - Mon Sep 08, 7:07AM CDT
Vancouver, BC / ACCESSWIRE / September 8th, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Phytalytics LLC. ("Phytalab.com" , its 51% controlled US subsidiary, has received provisional certification from the Washington State Liquor Control Board. This milestone enables the lab to legally offer service to the new legal Cannabis industry.
Abattis Announces Grant of Stock Options
ACCESSWIRE - Wed Aug 13, 7:43PM CDT
Vancouver, BC / ACCESSWIRE / August 13, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), the Company is pleased to announce that, in compliance with the Company's option plan, the Company has granted 455,000 incentive stock options to certain of its directors, officers and consultants, with each option being exercisable into a common share of Abattis at $0.43 per share for a period of five years.
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 68.08 (+1.82), FULL: 4.76 (-0.01)
Enertopia Provides Footage of Planned MMPR Facility
ACCESSWIRE - Thu Nov 20, 8:45AM CST
Whitefish, MT / ACCESSWIRE / November 20, 2014 / Thus far there has only been a handful of companies approved by Health Canada for the MMPR program, including Tweed Inc. (TSX-V: TWD) and Organigram Inc. (TSX-V: OGI), while a number of other companies, such as Abattis Bioceuticals (OTC: ATTBF) continue to await their approvals from Health Canada.
OGI.VN: 0.680 (+0.030), TWD.VN: 2.000 (-0.020)
Abattis Names Jaouad Fichtali as Chief Technology Officer
Marketwired - Wed Nov 19, 2:49PM CST
Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Jaouad Fichtali will assume the role of Chief Technology Officer of Abattis effective November 17, 2014. Court Orders Abattis Bioceuticals to Cease Emergency Motions Against Affinor Growers Inc., Affinor Growers LLC and Nick Brusatore. Judge Agrees There is No Basis for Such Claims by Abattis
Marketwired - Wed Nov 12, 7:24AM CST
Affinor Growers (CSE: AFI)(OTCQB: RSSFF)(FRANKFURT: 1AF) ("Affinor" or the "Corporation) In a Temporary Restraining Order hearing in Washington State, the court ordered that Affinor Growers Inc., Affinor Growers LLC and Nick Brusatore should not be included in these proceedings. Brusatore's lawyer, Kevin Sullivan, explained that there was no basis for such claims, and the judge agreed.
Abattis Obtains Emergency Temporary Restraining Order Against Defendants In King County, Washington State Court--Court Sets "SHOW Cause" Hearing Against Defendants For November ...
ACCESSWIRE - Tue Nov 11, 11:07AM CST
Vancouver, BC / ACCESSWIRE / November 11, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, wishes to advise its shareholders that late Monday afternoon, the Company obtained a temporary restraining order from the Washington state court in King County against Herbal Analytics, LLC, James Baxter, Kaleb Lund, Lauren Hilty, and Erin Leary (the "HA Defendants" . The Company agreed with the court to defer any action against Affinor Growers, Affinor Growers, LLC and Nicholas Brusatore, personally, until after the conclusion of a "Show Cause" hearing on preliminary injunctive relief. The Show Cause hearing is scheduled for argument on November 24, 2014 at which time all of the defendants must prove why a temporary injunction should not be entered by the court. Abattis Obtains Emergency Temporary Restraining Order Against Defendants In King County, Washington State Court--Court Sets "SHOW Cause" Hearing Against Defendants For November 24 Regarding the Imposition of a Preliminary Injunction
TheNewswire.ca - Tue Nov 11, 11:00AM CST
(via Thenewswire.ca)
Abattis Legal Action Goes From Federal to Washington State Court
ACCESSWIRE - Mon Nov 10, 4:01AM CST
Vancouver, BC /ACCESSWIRE / November 10, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that end of day Friday November 7th the company filed its suit in King County Superior Court, that it had previously filed in Federal court. It was filed end of day Friday. The hearing on it's motion for a temporary restraining order is scheduled Monday at 1:30 pm. Abattis Legal Proceedings Update
ACCESSWIRE - Fri Nov 07, 5:01PM CST
Vancouver, BC / ACCESSWIRE / November 7, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that the U.S. Federal Court in Washington State has this morning declined to exercise federal jurisdiction over the Company's recently announced claims. As a preliminary jurisdictional matter, the court indicated that it did not believe it was an appropriate venue for legal proceedings relating to the state's Marijuana industry. While the Court stated that the Company had fought "valiantly" during the hearing in advocating for federal jurisdiction, it also made plain that, unlike other jurisdictions throughout the U.S. which had exercised jurisdiction, it was bound by a prior legal decision from the ninth circuit that narrowed the ability of the Court to exercise federal jurisdiction in a similar case. The Court took the extraordinary step, however, of warning the defendants that it's decision to decline exercising federal jurisdiction should not be considered "a win" as the Company was likely to refile it's allegations in Washington state court. As predicted in the ruling, the Company is in preparations to immediately refile its complaint and seek a temporary restraining order on an emergency basis in Washington state court. Unlike the federal system, Washington state courts generally align more closely with state law on claims based on disputes within the Marijuana industry. The Company will keep shareholders informed as information becomes available throughout the day. Abattis Files for Injunctive Relief in Washington State and Claims Damages Against Former Employees, Business Associates and Competitor, Affinor Growers, Inc. and Certain of its...
ACCESSWIRE - Fri Oct 24, 2:41PM CDT
Vancouver, BC / ACCESSSWIRE / October 24, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that it has today, in U.S. Federal court in Washington State, filed suit for damages and injunctive relief against prior employees of PhytaLab (Dr. Kaleb Lund and Ms. Lauren Hilty), a former business associate (James Baxter), a competitor (Affinor Growers, Inc.), its director and former Abattis director (Nick Brusatore) and an employee of Herbal Analytics LLC (Erin Leary). Abattis Announces New Investor Relations Appointment
ACCESSWIRE - Thu Oct 16, 8:16AM CDT
Vancouver, BC / ACCESSWIRE / October 16, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that they have entered into an Investor Relations Consulting Agreement with Satvir (Saf) Dhillon. Abattis Announces Zoning Approval on the Experion MMPR Application
GlobeNewswire - Wed Oct 08, 8:48AM CDT
Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX:ATTBF) (CSE:ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that through its wholly owned subsidiary, Northern Vine Canada Inc. ("Northern Vine" , Experion Biotechnologies Inc. ("Experion" has received a written update from the Fraser Valley Regional District on the amended zoning regulations for its property which has now been approved for... "the use of cultivation, growth, storage, or distribution, testing, or research, of marijuana for medical purposes as lawfully permitted and authorized under the applicable federal or provincial law." Abattis Announces Appointment Guy Dancosse, Q.C. to Board of Directors
ACCESSWIRE - Tue Sep 16, 7:06AM CDT
Vancouver, BC - / ACCESSWIRE / September 16, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Guy Dancosse, Q.C. has agreed to join the Board effective immediately as an independent Director. Abattis' Phytalab Receives Cannabis Lab Certification in Washington
ACCESSWIRE - Mon Sep 08, 7:07AM CDT
Vancouver, BC / ACCESSWIRE / September 8th, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Phytalytics LLC. ("Phytalab.com" , its 51% controlled US subsidiary, has received provisional certification from the Washington State Liquor Control Board. This milestone enables the lab to legally offer service to the new legal Cannabis industry. Abattis Announces Grant of Stock Options
ACCESSWIRE - Wed Aug 13, 7:43PM CDT
Vancouver, BC / ACCESSWIRE / August 13, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTCQX: ATTBF) (CSE: ATT), the Company is pleased to announce that, in compliance with the Company's option plan, the Company has granted 455,000 incentive stock options to certain of its directors, officers and consultants, with each option being exercisable into a common share of Abattis at $0.43 per share for a period of five years. 
